Opendata, web and dolomites

ENDOGI SIGNED

The first multiple stent delivery system for the treatment of biliary, pancreatic and urologic strictures and stenosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ENDOGI project word cloud

Explore the words cloud of the ENDOGI project. It provides you a very rough idea of what is the project "ENDOGI" about.

post    endoscope    disrupt    urgent    consequence    disorders    stenosis    extended    mps    bile    medical    endoscopic    patency    stenting    certifications    cannulations    plastic    savings    passage    feasibility    gastrointestinal    urinary    initially    device    pancreatitis    diseases    company    disease    placement    people    specially    stent    retrograde    guidewire    50    securing    boost    cholangio    lumen    preliminary    pancreatography    safe    biliary    optimize    day    vascular    urologic    pig    duct    settings    restore    stents    20    completely    models    infections    secure    complications    carry    procedure    clinical    prevent    launch    validate    patented    liver    first    regulatory    endogi    innovation    64    treatment    hepatic    reduce    ducts    pancreatic    times    human    hospitalization    80    phantoms    drainage    penetrate    insertion    market    multiple    ischemia    hospitalizations    single    330    narrowing    obtain    ercp    tested    jaundice    procedural    prototype   

Project "ENDOGI" data sheet

The following table provides information about the project.

Coordinator
ENDO GI MEDICAL LTD 

Organization address
address: 13 WADI EL HAJ
city: NAZARETH
postcode: 16000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.endo-gi.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ENDO GI MEDICAL LTD IL (NAZARETH) coordinator 50˙000.00

Map

 Project objective

Gastrointestinal diseases affect more than 70 M of people only in US and many of them, e.g. biliary/pancreatic disorders, can have as a consequence biliary, pancreatic or other duct's narrowing (stenosis). In these cases, there is an urgent need to restore lumen patency and drainage in order to prevent complications (e.g. jaundice, infections, liver disease), and they are often treated long-term by stent placement with an ERCP (Endoscopic Retrograde Cholangio-Pancreatography). However, ERCP stenting (specially for multiple stents) still represents many potential complications, associated with extended procedural times and multiple cannulations, which increases the side-effects of the procedure and the ERCP and post-ERCP costs. EndoGI medical has developed the first patented multi-stent delivery system for treatment of biliary, pancreatic and urologic stenosis that allows the safe insertion of multiple plastic stents (MPS) in a controlled, secure and single step. It enables the insertion of 2 or more plastic stents in the bile, hepatic or urinary ducts at 1 endoscope passage and with securing the guidewire throughout the procedure. EndoGI system can reduce up to 50% the cost of hospitalization/day, up to 80% the cost of hospitalization derived from post-ERCP pancreatitis and up to 20% the costs of hospitalizations by ischemia, which represents a 64% of reduction in comparison with common procedure using MPS and 2 delivery systems. We have built-up a first prototype and preliminary tested it with human phantoms and pig models, and now we aim to optimize the device, completely validate it in clinical settings, obtain regulatory certifications and launch it to market. We will initially penetrate the non-vascular stents market and focus in biliary stenting to offer savings of Ëž€330 M/year only in EU. During Phase 1, we will carry out a detailed feasibility study to evaluate the opportunities our innovation has to disrupt the field and boost EndoGI company growth.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ENDOGI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ENDOGI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More  

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More